High Nasopharyngeal Cancer Screening Index: What You Need to Know - Otolaryngology

Share to:

The screening index for nasopharyngeal carcinoma is excessively high?


Hello, doctor.
In October, I went to the hospital for a health check-up, and the report revealed that my blood test showed an elevated level of the nasopharyngeal carcinoma marker.
The normal range for EB VCA IgA is below 0.91, but my level is 1.4.
A few days ago, I visited the ENT department, and the doctor performed a nasopharyngoscopy, which appeared normal.
I would like to ask if this means I do not have a nasopharyngeal carcinoma issue? Is there a need for any special follow-up? Thank you.

Eric, 20~29 year old female. Ask Date: 2012/11/03

Dr. Zheng Jueyi reply Otolaryngology


Dear: Hello, a high index for nasopharyngeal carcinoma does not necessarily indicate that one has the disease.
The definitive diagnosis of nasopharyngeal carcinoma still requires a nasopharyngeal biopsy, which should then be sent for pathological examination to confirm the diagnosis.
If the nasopharyngoscopy shows no abnormalities, it suggests that there is currently no possibility of nasopharyngeal carcinoma, and monitoring should suffice.
However, if there are persistent symptoms suggestive of nasopharyngeal carcinoma, such as the discovery of a neck mass, blood in morning sputum, persistent unilateral nasal obstruction or nosebleeds, a sensation of fullness in one ear, or ongoing unilateral headaches, medical evaluation and biopsy are necessary.
Wishing you peace and health.
Sincerely, Dr.
Cheng Jue-Yi, Attending Physician, Department of Otolaryngology, Taoyuan Hospital, Ministry of Health and Welfare.

Reply Date: 2012/11/03

More Info


When it comes to elevated levels of the nasopharyngeal cancer screening index, particularly the Epstein-Barr Virus (EBV) VCA IgA antibody test, it is essential to understand the implications of these results and the context in which they are interpreted. Your reported level of 1.4, which exceeds the normal range of 0.91, does raise some concerns, but it does not definitively indicate the presence of nasopharyngeal cancer.

EBV is a virus that is commonly associated with various conditions, including infectious mononucleosis and certain types of cancers, including nasopharyngeal carcinoma (NPC). The presence of EBV VCA IgA antibodies can be indicative of an immune response to the virus, which may occur in individuals who have been infected with EBV. Elevated levels of these antibodies are often seen in patients with NPC, but they can also be present in individuals without cancer, especially in endemic regions where EBV is prevalent.

The fact that your ENT specialist performed a nasopharyngoscopy and found no abnormalities is a positive sign. This procedure allows for direct visualization of the nasopharynx and can help identify any lesions or abnormalities that may not be detectable through imaging studies. Given that your examination was normal, it suggests that there may not be any immediate cause for concern regarding nasopharyngeal cancer.

However, it is important to note that elevated EBV VCA IgA levels can sometimes indicate other conditions, such as chronic EBV infection or other benign processes. Therefore, while your current examination results are reassuring, it may be prudent to continue monitoring your EBV levels and any symptoms you may experience.

In terms of follow-up, it is advisable to discuss with your healthcare provider whether additional testing or monitoring is necessary. This could include repeat blood tests to track changes in your EBV VCA IgA levels over time or further imaging studies if any new symptoms arise. Your healthcare provider may also consider other risk factors, such as family history, geographic location, and any symptoms you may have, to determine the best course of action.

In summary, while your elevated EBV VCA IgA level does warrant attention, the normal findings from your nasopharyngoscopy are encouraging. It is essential to maintain open communication with your healthcare provider regarding your results and any potential follow-up actions. Regular monitoring and a thorough understanding of your health status will help ensure that any potential issues are addressed promptly.

Similar Q&A

Understanding Nasopharyngeal Checkups: What You Need to Know About EBV and Cancer Risks

Hello Dr. Zheng, About two months ago, I visited an ENT specialist at a local hospital due to yellow-green nasal discharge with blood streaks, and I was diagnosed with sinusitis. Since there was blood present, the doctor performed a nasal endoscopy, which showed no abnormalities...


Dr. Zheng Jueyi reply Otolaryngology
Hello: Currently, the diagnosis of nasopharyngeal carcinoma is primarily based on nasopharyngoscopy and biopsy. If the numbers are elevated but the nasopharyngoscopy results are normal and there are no suspicious areas requiring biopsy, you may return for a follow-up in three mon...

[Read More] Understanding Nasopharyngeal Checkups: What You Need to Know About EBV and Cancer Risks


Understanding EBV: Key Insights for Patients with Nasopharyngeal Concerns

Hello, Dr. Zheng! I have the following questions I would like to ask. Thank you for taking the time to read this. I have been experiencing sudden double vision for a year, so I first consulted an ophthalmologist. The doctor recommended an MRI to check for any abnormalities in my ...


Dr. Zheng Jueyi reply Otolaryngology
Hello, currently, nasopharyngeal carcinoma is definitively diagnosed through nasopharyngeal biopsy. The EBV index can serve as a reference for physicians; however, a high index does not necessarily indicate nasopharyngeal carcinoma. It is recommended to have regular follow-up app...

[Read More] Understanding EBV: Key Insights for Patients with Nasopharyngeal Concerns


Understanding High Nasopharyngeal Cancer Screening Index: Key Insights

Hello Dr. Cheng, thank you for your response. I would like to ask you again whether the nasopharyngeal biopsy you mentioned is performed only when suspicious lesions are observed during the nasopharyngoscopy, or if tissue samples are taken for examination regardless of the presen...


Dr. Zheng Jueyi reply Otolaryngology
Dear Eric, Typically, a biopsy is performed only when suspicious lesions are observed during a nasopharyngoscopy. If the examination of the nasopharynx is normal, a blind biopsy is not indicated. Under normal circumstances, it is recommended to follow up in 3 to 6 months. Wishi...

[Read More] Understanding High Nasopharyngeal Cancer Screening Index: Key Insights


Understanding Nasopharyngeal Cancer Risk: Key Insights for Patients

Hello Doctor, I would like to ask you a question. Before the Lunar New Year, I had a cold and went to the hospital for an examination. During the process, I mentioned to the doctor that I had undergone surgery on my left nostril, and my family has reported that my snoring has bec...


Dr. Ji Zhaoyun reply Otolaryngology
Hello, nasopharyngeal carcinoma is a high-risk group and should not be assessed solely through blood tests. It is recommended to return to the original physician for a comprehensive evaluation and opinion.

[Read More] Understanding Nasopharyngeal Cancer Risk: Key Insights for Patients


Related FAQ

Nasopharyngeal Carcinoma

(Otolaryngology)

Nasopharyngeal Examination

(Otolaryngology)

Nasopharyngeal Cancer

(Oncology)

Nasopharynx

(Otolaryngology)

Lymphadenopathy

(Otolaryngology)

Throat Disease

(Otolaryngology)

Parotid Tumor

(Otolaryngology)

Hearing Test

(Otolaryngology)

Mumps

(Otolaryngology)

Sleep Apnea

(Otolaryngology)